The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwergal, A.
Right arrow Articles by Brand, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwergal, A.
Right arrow Articles by Brand, K.
The Journal of Immunology, 2006, 177: 665-672.
Copyright © 2006 by The American Association of Immunologists

C/EBPbeta Blocks p65 Phosphorylation and Thereby NF-{kappa}B-Mediated Transcription in TNF-Tolerant Cells1

Andreas Zwergal2,*, Martina Quirling2,*, Bernd Saugel*, Karin C. Huth{dagger}, Carmen Sydlik*, Valeria Poli{ddagger}, Dieter Neumeier*, H. W. Löms Ziegler-Heitbrock§ and Korbinian Brand3,*

* Institute of Clinical Chemistry and Pathobiochemistry, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; {dagger} Department of Restorative Dentistry and Periodontology, Ludwig-Maximilians-University, Munich, Germany; {ddagger} Department of Genetics, Biology, and Biochemistry, University of Turin, Turin, Italy; § Clinical Cooperation Group Inflammatory Lung Diseases, GSF-Forschungszentrum für Umwelt und Gesundheit-Institute of Inhalation Biology, Gauting, Germany; and Department of Microbiology and Immunology, University of Leicester, Leicester, United Kingdom

TNF is a major mediator of inflammation, immunity, and apoptosis. Pre-exposure to TNF reduces sensitivity to restimulation, a phenomenon known as tolerance, considered as protective in sepsis, but also as a paradigm for immunoparalysis. Earlier experiments in TNF-tolerant cells display inhibition of NF-{kappa}B-dependent IL-8 gene expression at the transcriptional level with potential involvement of C/EBPbeta. In this study, we have shown that a {kappa}B motive was sufficient to mediate transcriptional inhibition under TNF tolerance conditions in monocytic cells. Furthermore, in tolerant cells, TNF-induced NF-{kappa}B p65 phosphorylation was markedly decreased, which was accompanied by the formation of C/EBPbeta-p65 complexes. Remarkably, in C/EBPbeta–/– cells incubated under the conditions of TNF tolerance, neither impairment of transcription nor inhibition of p65 phosphorylation was observed. Finally, we showed that C/EBPbeta overexpression reduced p65-mediated transactivation and that association of C/EBPbeta with p65 specifically prevented p65 phosphorylation. Our data demonstrate that C/EBPbeta is an essential signaling component for inhibition of NF-{kappa}B-mediated transcription in TNF-tolerant cells and suggest that this is caused by blockade of p65 phosphorylation. These results define a new molecular mechanism responsible for TNF tolerance in monocytic cells that may contribute to the unresponsiveness seen in patients with sepsis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Du, N. Hiramatsu, K. Hayakawa, A. Kasai, M. Okamura, T. Huang, J. Yao, M. Takeda, I. Araki, N. Sawada, et al.
Suppression of NF-{kappa}B by Cyclosporin A and Tacrolimus (FK506) via Induction of the C/EBP Family: Implication for Unfolded Protein Response
J. Immunol., June 1, 2009; 182(11): 7201 - 7211.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Neumann and M. Naumann
Beyond I{kappa}Bs: alternative regulation of NF-{kappa}B activity
FASEB J, September 1, 2007; 21(11): 2642 - 2654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.